Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Lekoujia Biotechnology Co., Ltd. is a Chinese life sciences company specializing in the research, development, and commercialization of functional probiotics and nutritional supplements. Founded in 2013 and headquartered in Beijing, the company focuses on the maternal and infant health segment, providing evidence-based probiotic solutions to support gut health and immunity. Lekoujia maintains strategic partnerships with global bioscience leaders, such as Chr. Hansen, to incorporate clinically validated probiotic strains like Bifidobacterium animalis BB-12 and Lactobacillus rhamnosus LGG into its formulations. The company's product portfolio includes probiotic powders, drops, and chewables, alongside nutritional supplements like lactoferrin and vitamins. Lekoujia has established itself as a prominent consumer healthcare brand in China through its focus on high-quality, scientifically backed nutritional products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lekoujia.